WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 3rd, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of October 2, 2019, is between Jaguar Health, Inc. (the “Company”) and the purchaser signatory thereto (the “Purchaser”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) and the Series 1 Warrants (as defined below).
